KATHERINE ADAMS: Open Payments
NPI 1710229208 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 22 payments from 12 companies in 2025. Trend: 2023 $505 · 2024 $541 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $72 |
| Astellas Pharma US Inc | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Exact Sciences Corporation | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Boston Scientific Corporation | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Abbott Laboratories | 1 | $19 |
Products named: Veozah, JARDIANCE, Cologuard Collection Kit, NURTEC ODT, FANAPT, MOUNJARO, WATCHMAN FLX, ELIQUIS.
Industry payments across FL — which companies pay providers there.
